Dr. Razelle Kurzrock, lead PI, discusses the importance of including treating physicians into the TRACK Molecular Tumor Board meetings. As discussed on Rare Cancer Day 2020.
- About
- About TCF
- Our Impact
- Our Team
- Partners & Collaborators
- News & Updates
- Frequently Asked Questions
- Financials
- Learn
- Rare Cancer Resources
- What is a Rare Cancer?
- Initial Steps After a Rare Cancer Diagnosis
- Biomarker Testing in Rare Cancers
- Clinical Trials
- Video Library
- Glossary
- Research
- Events
- TCF Events
- TargetCancer Foundation Gala
- A Night to Strike Out Rare Cancer
- Webinars
- Scientific Meetings
- Boston Marathon
- Rare Cancer Day
- Get Involved
- Blog
- Contact